Shuting Han

1.2k citations
22 papers · 500 · h-index 12

Impact in

Papers in

    • COVID-19 and healthcare impacts 3
    • Viral-associated cancers and disorders 2
    • Cancer Immunotherapy and Biomarkers 2
    • CAR-T cell therapy research 2
    • RNA modifications and cancer 3
    • Molecular Biology Techniques and Applications 2

Shuting Han

20 papers receiving 497 citations

Peers

Shuting Han
Comparison fields: 5 of 78
  • Cancer Research 165
  • Orthopedics and Sports Medicine 43
  • Oncology 133
  • Molecular Biology 248
  • Otorhinolaryngology 8
Replace Semih Doğan with:
Semih Doğan Türkiye
Xiaoyong Zheng China
Fabrizio Citarella Italy
Haining Li China
Cristian Virgil Lungulescu Romania
Haoyuan Jia China
M. Kaneko Japan
Paul A. Kaplan United States
C. Matthias Wilk Switzerland
Shuting Han relative to Semih Doğan Türkiye Semih Doğan's profile →
Citations per field
00.5×
Semih Doğan · 1×
Citations per year

Countries citing papers authored by Shuting Han

Since Specialization
Citations

This map shows the geographic impact of Shuting Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Han more than expected).

Fields of papers citing papers by Shuting Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuting Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Han. The network helps show where Shuting Han may publish in the future.

Co-authors

The 25 scholars most cited alongside Shuting Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuting Han Line = papers co-authored together Shuting Han links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019159
2 202171
3 201258
4 202143
5 202236
6 202022
7
Anemia is associated with poor outcomes of metastatic castration-resistant prostate cancer, a systematic review and meta-analysis.
201820
8 202314
9 202012
10 201911
11 202011
12 202211
13 20229
14 20207
15 20255
16 20194
17 20243
18 20212
19 20181
20 20191

About Shuting Han

Shuting Han is a scholar working on Oncology, Molecular Biology, Cancer Research, Epidemiology and Surgery, having authored 22 papers that have together received 500 indexed citations. Recurring topics across this work include Advances in Oncology and Radiotherapy (3 papers), COVID-19 and healthcare impacts (3 papers), RNA modifications and cancer (3 papers), Cancer Genomics and Diagnostics (2 papers), Viral-associated cancers and disorders (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Molecular Biology Techniques and Applications (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (165 citations), Orthopedics and Sports Medicine (43 citations), Oncology (133 citations), Molecular Biology (248 citations) and Otorhinolaryngology (8 citations). Shuting Han has collaborated with scholars based in Singapore, China and United States. Frequent co-authors include Hongchuan Jin, Xian Wang, Lifeng Feng, Yiran Zhu, Miaoqin Chen, Liyuan Zhu, Ping Song, Dongjun Dai, Han Chong Toh and Wenxia Xu. Their work appears in journals such as Frontiers in Genetics, Analytical Biochemistry, Medicine, Journal of Cancer Policy and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact